| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9K | +133.8% | — |
| Cost of Revenue | $4K | +85.7% | — |
| Gross Profit | $5K | +200.6% | — |
| R&D Expense | $524K | +31.0% | +13.9% |
| SG&A Expense | $1.2M | -11.9% | -67.2% |
| Operating Income | -$1.7M | +2.5% | +58.4% |
| Pre-tax Income | -$4.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $161K | +40.0% | — |
| Accounts Receivable | $6K | +8.8% | +456.6% |
| Inventory | $24K | +0.0% | +0.0% |
| Current Assets | $1.0M | -17.5% | -50.4% |
| Total Assets | $5.1M | -4.7% | -16.6% |
| Total Liabilities | $22.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | — | — |
| Capital Expenditures | $118K | — | — |
| Investing Cash Flow | -$214K | — | — |
| Financing Cash Flow | $628K | — | — |
| Free Cash Flow | -$3.7M | — | — |
| +38.3% |
| Net Income | -$4.1M | -2887.7% | +38.3% |
| EPS (Basic) | -$1.33 | -2760.0% | -1800.0% |
| EPS (Diluted) | -$1.33 | -2760.0% | +58.8% |
| +31.0% |
| -9.6% |
| Stockholders' Equity | -$17.4M | -47.1% | +7.3% |